Walter Licht of the School of Arts and Sciences discusses mining-safety citations.
Penn in the News
Walter Licht of the School of Arts and Sciences says increased fines would force the mining industry to improve safety standards.
Deborah Linebarger of the Annenberg School for Communication says most TV shows geared towards children may be detrimental to ages 2 and younger.
Jonathan Moreno of the School of Medicine and the School of Arts and Sciences says drug trial consent forms are many times too cryptic for the average potential patient to fully comprehend.
Donald Kettl of the School of Arts and Sciences authors a column examining the mental state of returning Iraq war veterans.
Gary Gorton of the Wharton School is cited for his research on stocks and commodities.
Dean Michael Delli Carpini of the Annenberg School for Communication says media strategies to broaden audience can have a negative effect on content quality.
Jack Guttentag of the Wharton School authors an op-ed on the relationship between mortgage brokers and their borrowers.
Krishna and Martha Singh are profiled as donors to the School of Engineering and Applied Science.
The Center for High Impact Philanthropy in the School of Social Policy and Practice is profiled.
Penn’s sustainability plan is highlighted.
Penn’s employee-health program, Penn Walkers, is profiled.
President Amy Gutmann discusses Penn's commitment to need-based financial aid.
Dean Michael Delli Carpini of the Annenberg School for Communication discusses the plan to safeguard Wall Street Journal editorial content following the sale of the newspaper’s parent company.
Stephen Hoch of the Wharton School says marketing strategies can prove difficult in superstores.
Arthur Caplan of the School of Medicine says many people have fears about organ donation.
Marybeth Gasman of the Graduate School of Education discusses historically black universities.
H. Lee Sweeney of the School of Medicine discusses gene-doping.
Peter Cappelli of the Wharton School discusses younger employees’ work ethic.
Sean Hennessy of the School of Medicine discusses the risks of certain acne drugs.